Impact of the neuroendocrine system on thymus and bone marrow function

NeuroImmunoModulation

Volumn 15, Issue 1, 2008, Pages 7-18

  Barnard, Adele ^a   Layton, Daniel ^a   Hince, Melanie ^a   Sakkal, Samy ^a   Bernard, Claude ^a   Chidgey, Ann ^a   Boyd, Richard ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Bone marrow; Estrogen; Glucocorticoid; Growth hormone; Immune system; Neuroendocrine system; Progesterone; Prolactin; Testosterone; Thymus

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FOLLITROPIN; GAMMA INTERFERON; GLUCOCORTICOID; GONADORELIN ANTAGONIST; GROWTH HORMONE; HYDROCORTISONE; INTERLEUKIN 1; INTERLEUKIN 6; LUTEINIZING HORMONE; NANDROLONE DECANOATE; OXYTOCIN; PROGESTERONE; PROLACTIN; PROSTAGLANDIN; SOMATOMEDIN C; STEROID HORMONE; T LYMPHOCYTE RECEPTOR; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA; VASOPRESSIN;

AGING; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; BONE MARROW; CASTRATION; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DRUG POTENTIATION; ESTROGEN THERAPY; FEEDBACK SYSTEM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HORMONAL REGULATION; HORMONE ACTION; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNOMODULATION; INFECTION; INFLAMMATION; INFLAMMATORY DISEASE; LYMPHOCYTE SUBPOPULATION; LYMPHOPOIESIS; MENOPAUSAL SYNDROME; MUSCLE ATROPHY; MYASTHENIA GRAVIS; NONHUMAN; ORGANOGENESIS; POSTMENOPAUSE OSTEOPOROSIS; PREGNANCY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REVIEW; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; THYMOCYTE; THYMUS FUNCTION; TISSUE INJURY; UNSPECIFIED SIDE EFFECT;

AGING; ANIMALS; BONE MARROW; FEEDBACK; HOMEOSTASIS; HORMONES; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; NEUROIMMUNOMODULATION; NEUROSECRETORY SYSTEMS; THYMUS GLAND;

EID: 48349133919     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000135619     Document Type: Review

References (97)

1. Berczi I: The stress concept and neuroimmunoregulation in modern biology. Ann NY Acad Sci 1998;851:3-12.
2. Isakovic K, Jankovic BD: Neuro-endocrine correlates of immune response. II. Changes in the lymphatic organs of brain-lesioned rats. Int Arch Allergy Appl Immunol 1973;45:373-384.
3. Raff M: Theta isoantigen as a marker of thymus-derived lymphocytes in mice. Nature 1969;224:378-379.
4. Allman D, et al: An invitation to T and more: notch signaling in lymphopoiesis. Cell 2002;109(suppl):S1-S11.
5. Saito T, Watanabe N: Positive and negative thymocyte selection. Crit Rev Immunol 1998;18:359-370.
6. Chandratilleke D, Marsh JA: The effect of thymulin on avian IL-2 receptor expression. Int J Immunopharmacol 2000;22:887-896.
7. Kopf-Maier P, Mboneko VF: Anomalies in the hormonal status of athymic nude mice. J Cancer Res Clin Oncol 1990;116:229-231.
8. Smith EM, Blalock JE: A molecular basis for interactions between the immune and neuroendocrine systems. Int J Neurosci 1988;38:455-464.
9. Trainor PA, Krumlauf R: Patterning the cranial neural crest: hindbrain segmentation and Hox gene plasticity. Nat Rev Neurosci 2000;1:116-124.
10. Moll UM: Functional histology of the neuroendocrine thymus. Microsc Res Tech 1997;38:300-310.
11. Haynes BF, Shimizu K, Eisenbarth GS: Identification of human and rodent thymic epithelium using tetanus toxin and monoclonal antibody A2B5. J Clin Invest 1983;71:9-14.
12. Paulo LG, et al: Effects of acute posterior hypothalamic stimulation on bone marrow microcirculation and reticulocyte release. Agents Actions 1973;3:385.
13. Fedorov NA, Likhovetskaia ZM, L'Vovich I, Gemopoez A: Hematopoiesis in rats with destroyed posterior hypothalamic nuclei using the absolute number of bone marrow cells as an index (in Russian). Biul Eksp Biol Med 1980;89:349-351.
14. Kincade PW, et al: Early B-lymphocyte precursors and their regulation by sex steroids. Immunol Rev 2000;175:128-137.
15. Woody MA, et al: Use of neuroendocrine hormones to promote reconstitution after bone marrow transplantation. Neuroimmunomodulation 1999;6:69-80.
16. Lempereur L, et al: Growth hormone protects human lymphocytes from irradiation-induced cell death. Br J Pharmacol 2003;138:1411-1416.
17. Timsit J, et al: Growth hormone and insulin-like growth factor-I stimulate hormonal function and proliferation of thymic epithelial cells. J Clin Endocrinol Metab 1992;75:183-188.
18. Chidgey AP, Boyd RL: Stemming the tide of thymic aging. Nat Immunol 2006;7:1013-1016.
19. Sutherland JS, et al: Activation of thymic regeneration in mice and humans following androgen blockade. J Immunol 2005;175:2741-2753.
20. Goya RG, Brown OA, Bolognani F: The thymus-pituitary axis and its changes during aging. Neuroimmunomodulation 1999;6:137-142.
21. Marston BJ, et al: Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med 1997;157:1709-1718.
22. Sakabe K, et al: Inhibitory effect of natural and environmental estrogens on thymic hormone production in thymus epithelial cell culture. Int J Immunopharmacol 1999;21:861-868.
23. Staples JE, et al: Estrogen receptor alpha is necessary in thymic development and estradiol-induced thymic alterations. J Immunol 1999;163:4168-4174.
24. Zoller AL, Kersh GJ: Estrogen induces thymic atrophy by eliminating early thymic progenitors and inhibiting proliferation of beta-selected thymocytes. J Immunol 2006;176:7371-7378.
25. Yellayi S, et al: Normal development of thymus in male and female mice requires estrogen/estrogen receptor-alpha signaling pathway. Endocrine 2000;12:207-213.
26. Islander U, et al: Estren-mediated inhibition of T lymphopoiesis is estrogen receptor-independent whereas its suppression of T cell-mediated inflammation is estrogen receptor-dependent. Clin Exp Immunol 2005;139:210-215.
27. Yao G, Hou Y: Thymic atrophy via estrogen-induced apoptosis is related to Fas/FasL pathway. Int Immunopharmacol 2004;4:213-221.
28. Forsberg JG: Neonatal estrogen treatment and its consequences for thymus development, serum level of autoantibodies to cardiolipin, and the delayed-type hypersensitivity response. J Toxicol Environ Health A 2000;60:185-213.
29. Greenstein BD, de Bridges EF, Fitzpatrick FT: Aromatase inhibitors regenerate the thymus in aging male rats. Int J Immunopharmacol 1992;14:541-553.
30. Jilka RL, et al: Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow. Evidence for autonomy from factors released during bone resorption. J Clin Invest 1998;101:1942-1950.
31. Sunyer T, et al: Estrogen's bone-protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells. J Clin Invest 1999;103:1409-1418.
32. Medina KL, Kincade PW: Pregnancy-related steroids are potential negative regulators of B lymphopoiesis. Proc Natl Acad Sci USA 1994;91:5382-5386.
33. Ryan MR, et al: An IL-7-dependent rebound in thymic T cell output contributes to the bone loss induced by estrogen deficiency. Proc Natl Acad Sci USA 2005;102:16735-16740.
34. Chidgey A, et al: Impact of niche aging on thymic regeneration and immune reconstitution. Semin Immunol 2007;19:331-340.
35. Moolman JA: Unravelling the cardioprotective mechanism of action of estrogens. Cardiovasc Res 2006;69:777-780.
36. Strehlow K, et al: Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 2003;107:3059-3065.
37. McCruden AB, Stimson WH: Androgen binding cytosol receptors in the rat thymus: physicochemical properties, specificity and localisation. Thymus 1981;3:105-117.
38. Viselli SM, et al: Immunochemical and flow cytometric analysis of androgen receptor expression in thymocytes. Mol Cell Endocrinol 1995;109:19-26.
39. Olsen NJ, et al: Androgen receptors in thymic epithelium modulate thymus size and thymocyte development. Endocrinology 2001;142:1278-1283.
40. Hareramadas B, Rai U: Mechanism of androgen-induced thymic atrophy in the wall lizard, Hemidactylus flaviviridis: an in vitro study. Gen Comp Endocrinol 2005;144:10-19.
41. Heng TS, et al: Effects of castration on thymocyte development in two different models of thymic involution. J Immunol 2005;175:2982-2993.
42. Dulos GJ, Bagchus WM: Androgens indirectly accelerate thymocyte apoptosis. Int Immunopharmacol 2001;1:321-328.
43. Viselli SM, et al: Androgens alter B cell development in normal male mice. Cell Immunol 1997;182:99-104.
44. Conneely OM, Mulac-Jericevic B, Lydon JP: Progesterone-dependent regulation of female reproductive activity by two distinct progesterone receptor isoforms. Steroids 2003;68:771-778.
45. Butts CL, et al: Evaluation of steroid hormone receptor protein expression in intact cells using flow cytometry. Nucl Recept Signal 2007;5:e007.
46. Weinstein Y, Lindner HR, Eckstein B: Thymus metabolises progesterone-possible enzymatic marker for T lymphocytes. Nature 1977;266:632-633.
47. Khamashta MA: Systemic lupus erythematosus and pregnancy. Best Pract Res Clin Rheumatol 2006;20:685-694.
48. Jacobi AM, et al: Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity. Lupus 2001;10:554-561.
49. Ruiz-Irastorza G, et al: Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies. Br J Rheumatol 1996;35:133-138.
50. Mecacci F, et al: The impact of autoimmune disorders and adverse pregnancy outcome. Semin Perinatol 2007;31:223-226.
51. Garay L, et al: Effects of progesterone in the spinal cord of a mouse model of multiple sclerosis. J Steroid Biochem Mol Biol 2007;107:228-237.
52. Weigent DA: Immunoregulatory properties of growth hormone and prolactin. Pharmacol Ther 1996;69:237-257.
53. Kopchick JJ, Andry JM: Growth hormone (GH), GH receptor, and signal transduction. Mol Genet Metab 2000;71:293-314.
54. Mello-Coelho V, et al: Growth hormone and its receptor are expressed in human thymic cells. Endocrinology 1998;139:3837-3842.
55. Li S, et al: Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 1990;347:528-533.
56. Fabris N, Pierpaoli W, Sorkin E: Hormones and the immunological capacity. 3. The immunodeficiency disease of the hypopituitary Snell-Bagg dwarf mouse. Clin Exp Immunol 1971;9:209-225.
57. Murphy WJ, et al: Immunologic and hematologic effects of neuroendocrine hormones. Studies on DW/J dwarf mice. J Immunol 1992;148:3799-3805.
58. Taub DD, et al: Growth hormone promotes human T cell adhesion and migration to both human and murine matrix proteins in vitro and directly promotes xenogeneic engraftment. J Clin Invest 1994;94:293-300.
59. Carlo-Stella C, et al: Use of recombinant human growth hormone (rhGH) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the mobilization and collection of CD34+ cells in poor mobilizers. Blood 2004;103:3287-3295.
60. Napolitano LA, et al: Growth hormone enhances thymic function in HIV-1-infected adults. J Clin Invest 2008;118:1085-1098.
61. Weigent DA: Immunoregulatory properties of growth hormone and prolactin. Pharmacol Ther 1996;69:237-257.
62. Kelly PA, et al: Prolactin receptor signal transduction pathways and actions determined in prolactin receptor knockout mice. Biochem Soc Trans 2001;29:48-52.
63. DaSilva L, et al: Prolactin recruits STAT1, STAT3 and STAT5 independent of conserved receptor tyrosines TYR402, TYR479, TYR515 and TYR580. Mol Cell Endocrinol 1996;117:131-140.
64. Dardenne M, et al: Neuroendocrine control of thymic hormonal production. I. Prolactin stimulates in vivo and in vitro the production of thymulin by human and murine thymic epithelial cells. Endocrinology 1989;125:3-12.
65. Dardenne M, et al: Prolactin receptor expression in human hematopoietic tissues analyzed by flow cytofluorometry. Endocrinology 1994;134:2108-2114.
66. Carreno PC, et al: Prolactin affects both survival and differentiation of T-cell progenitors. J Neuroimmunol 2005;160:135-145.
67. Carreno PC, et al: Prolactin stimulates maturation and function of rat thymic dendritic cells. J Neuroimmunol 2004;153:83-90.
68. Krishnan N, et al: Prolactin suppresses glucocorticoid-induced thymocyte apoptosis in vivo. Endocrinology 2003;144:2102-2110.
69. Gagnerault MC, et al: Expression of prolactin receptors in murine lymphoid cells in normal and autoimmune situations. J Immunol 1993;150:5673-5681.
70. Woody MA, et al: Prolactin exerts hematopoietic growth-promoting effects in vivo and partially counteracts myelosuppression by azidothymidine. Exp Hematol 1999;27:811-816.
71. Ogueta S, et al: Prolactin is a component of the human synovial liquid and modulates the growth and chondrogenic differentiation of bone marrow-derived mesenchymal stem cells. Mol Cell Endocrinol 2002;190:51-63.
72. Elands J, Resink A, De Kloet ER: Neurohypophyseal hormone receptors in the rat thymus, spleen, and lymphocytes. Endocrinology 1990;126:2703-2710.
73. Moll UM, et al: The neuroendocrine thymus. Abundant occurrence of oxytocin-, vasopressin-, and neurophysin-like peptides in epithelial cells. Histochemistry 1988;89:385-390.
74. Hansenne I, et al: Neurohypophysial receptor gene expression by thymic T cell subsets and thymic T cell lymphoma cell lines. Clin Dev Immunol 2004;11:45-51.
75. Grossman A, et al: Immune modulation of the hypothalamic-pituitary- adrenal axis. Cytokines and gases in the hypothalamus. Ann NY Acad Sci 1997;823:225-233.
76. Purton JF, et al: Intrathymic T cell development and selection proceeds normally in the absence of glucocorticoid receptor signaling. Immunity 2000;13:179-186.
77. Pruett SB, Padgett EL: Thymus-derived glucocorticoids are insufficient for normal thymus homeostasis in the adult mouse. BMC Immunol 2004;5:24.
78. Cole TJ, et al: Molecular genetic analysis of glucocorticoid signaling during mouse development. Steroids 1995;60:93-96.
79. Weaver JA: Changes induced in the thymus and lymph nodes of the rat by the administration of cortisone and sex hormones and by other procedures. J Pathol Bacteriol 1955;69:133-139.
80. Inomata T, et al: Influence of adrenalectomy on the developing rat thymus during peri-weaning period. Anat Histol Embryol 1993;22:296-299.
81. Purton JF, et al: Expression of the glucocorticoid receptor from the 1A promoter correlates with T lymphocyte sensitivity to glucocorticoid-induced cell death. J Immunol 2004;173:3816-3824.
82. Sutherland JS, et al: Enhanced Immune system regeneration in humans following allogeneic or autologous hemopoietic stem cell transplantation by temporary sex steroid blockade. Clin Cancer Res 2008;14:1138-1149.
83. Hince M, et al: The role of sex steroids and gonadectomy in the control of thymic involution. Cell Immunol 2008, E-pub ahead of print.
84. Goldberg GL, et al: Enhanced immune reconstitution by sex steroid ablation following allogeneic hemopoietic stem cell transplantation. J Immunol 2007;178:7473-7484.
85. Peeva E, Zouali M: Spotlight on the role of hormonal factors in the emergence of autoreactive B-lymphocytes. Immunol Lett 2005;101:123-143.
86. Grimaldi CM, et al: Hormonal modulation of B cell development and repertoire selection. Mol Immunol 2005;42:811-820.
87. Sthoeger ZM, Zinger H, Mozes E: Beneficial effects of the anti-oestrogen tamoxifen on systemic lupus erythematosus of (NZB! NZW)F1 female mice are associated with specific reduction of IgG3 autoantibodies. Ann Rheum Dis 2003;62:341-346.
88. Petri MA, et al: Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus. Arthritis Rheum 2004;50:2858-2868.
89. Nancy P, Berrih-Aknin S: Differential estrogen receptor expression in autoimmune myasthenia gravis. Endocrinology 2005;146:2345-2353.
90. Tengstrand B, et al: Abnormal levels of serum dehydroepiandrosterone, estrone, and estradiol in men with rheumatoid arthritis: high correlation between serum estradiol and current degree of inflammation. J Rheumatol 2003;30:2338-2343.
91. Sicotte NL, et al: Testosterone treatment in multiple sclerosis: a pilot study. Arch Neurol 2007;64:683-688.
92. Grinspoon S, et al: Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting. J Clin Endocrinol Metab 1996;81:4051-4058.
93. Ellis KJ, et al: Changes in body composition of human immunodeficiency virus-infected males receiving insulin-like growth factor I and growth hormone. J Clin Endocrinol Metab 1996;81:3033-3038.
94. Strawford A, et al: Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss. J Acquir Immune Defic Syndr Hum Retrovirol 1999;20:137-146.
95. Rossouw JE, et al: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
96. Moskowitz D: A comprehensive review of the safety and efficacy of bioidentical hormones for the management of menopause and related health risks. Altern Med Rev 2006;11:208-223.
97. Barnard AL, et al: Androgen depletion increases the efficacy of bone marrow transplantation in ameliorating experimental autoimmune encephalomyelitis. Manuscript in preparation.